Healthcare ❯ Pharmaceuticals

Drug Manufacturing

Quality Control Tariffs Active Pharmaceutical Ingredients Domestic Production Active Ingredients Supply Chain Weight Loss Drugs Market Trends Biosimilars Supply Chain Management Chemical Sourcing Specialty Drugs Laboratory Regulations Regulatory Environment Import Regulations Bulk Drug Imports Controlled Substances Production Strategies Fentanyl Production U.S. Expansion Plans Drug Exports Diabetes Treatment Biologics Production Novo Nordisk Price Regulation Chronic Diseases U.S. Manufacturing Cost Management Drug Investment Sales Performance U.S. Drug Policy FDA Regulations Research and Development Regulatory Issues Gene Therapy Trade Policies

Pfizer Tops Q3 Forecasts, Raises Profit Outlook

Cost reductions lifted the profit outlook despite softer sales.

FDA Drug Approvals Slowed in Q3 as Missed Deadlines and CRLs Rose

Merck Breaks Ground on $3 Billion Virginia Plant in $70 Billion U.S. Expansion